M1 Kliniken AG continues growth course
| Investor News
- Significant expansion of site capacities in Germany and internationally
- Sales in the "Beauty" segment well above the previous year's figures. Expected annual sales of over EUR 50 million in the Beauty segment in 2021
Berlin, 20.09.2021 - M1 Kliniken AG (ISIN: DE000A0STSQ8) sustainably continues its growth course in the third quarter of 2021. In the core market Germany alone, five new clinics have been opened in the current financial year. These clinics have been able to achieve pleasing occupancy and revenue figures already at a very early stage. With Aachen, another location is scheduled to open in October 2021. Further locations have been acquired in Würzburg and Wolfsburg.
M1 is also picking up speed abroad. Before the end of December, Brisbane will be the third location in Australia to open its doors. In The Hague, renovation work is underway for the third location in the Netherlands, which is also scheduled to open in December. Furthermore, authorisation applications for two more locations in Austria have been submitted.
The positive development is also reflected in M1's key performance figures. In the two summer months of July and August 2021, sales in the German injection clinics were 14% above the previous year's figures which were positively affected by catch-up effects from the lockdown that ended in mid-May 2020. Revenue in the international locations grew by more than 50% compared to the same two months of the previous year. For September 2021, M1 Kliniken AG has set course for a new record month. On 2 September 2021, the German specialist clinics were able to book a daily sales record. Based on the current development, M1 expects total sales in the "Beauty" sector to exceed EUR 50 million in 2021.